You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies

  • Authors: Robert Hauser, MD, MBA; Horacio Kaufmann, MD; William B. White, MD
  • CME Released: 12/4/2014; Reviewed and Renewed: 5/18/2016
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 5/18/2017
Start Activity


Target Audience and Goal Statement

This activity is intended for neurologists, primary care providers, cardiologists, nurses, and pharmacists who care for patients with autonomic disturbances.

The goal of this activity is to improve physicians' knowledge and competency in diagnosing and designing appropriate treatment regimens for patients with neurogenic orthostatic hypotension (nOH).

Upon completion of this activity, participants will be able to:

  1. Identify patients at higher risk for nOH and list the factors that elevate risk
  2. Discuss the diagnostic criteria and patient presentation for nOH
  3. Evaluate the evidence for available and emerging treatments for nOH to integrate new therapies into patient management strategies


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator(s)

  • Robert A. Hauser, MD, MBA

    Professor of Neurology, Molecular Pharmacology, and Physiology; Director, USF Health Byrd Parkinson's Disease and Movement Disorders Center of Excellence, National Parkinson Foundation Center of Excellence, Tampa, Florida

    Disclosures

    Disclosure: Robert Hauser, MD, MBA, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie Inc.; Allergan, Inc.; Auspex Pharmaceuticals; AstraZeneca Pharmaceuticals LP; Biotie Therapies Corp; Ceregene; Chelsea Therapeutics, Inc.; Cleveland Clinic; GE Healthcare; Gerson Lehrman Group; GLG Pharma, LLC; HealthLogiX; IMPAX Laboratories, Inc.; Indus Pharma; Ipsen; Lilly; Lundbeck, Inc.; Merck & Co., Inc.; Merck Sharp & Dohme Corp.; Noven Pharmaceuticals, Inc.; Pfizer Inc; Pricespective; Strakan Pharmaceuticals Ltd; Targacept, Inc.; Teva Neuroscience, Inc.; Teva Pharmaceuticals USA; UCB Pharma, Inc.; Upsher-Smith Laboratories, Inc.; US WorldMeds, LLC; XenoPort, Inc.; Zambon Company SpA

    Dr Hauser does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Hauser does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

  • Horacio Kaufmann, MD

    Professor of Neurology and Medicine; Director, Dysautonomia Center, New York University Langone Medical Center, New York, New York

    Disclosures

    Disclosure: Horacio Kaufmann, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Lundbeck, Inc.

    Dr Kaufmann does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Kaufmann does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • William B. White, MD

    Professor and Division Chief, Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, Connecticut

    Disclosures

    Disclosure: William B. White, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Roche; Takeda Pharmaceuticals North America, Inc.

    Dr White does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr White does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Ronald K. Miller, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies

Authors: Robert Hauser, MD, MBA; Horacio Kaufmann, MD; William B. White, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 12/4/2014; Reviewed and Renewed: 5/18/2016

Valid for credit through: 5/18/2017

processing....

 
 
 
 

This feature requires the newest version of Flash. You can download it here.
  • Print